These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33841627)

  • 1. The COVID-19 pandemic and the potential treatment of the novel coronavirus SARS-CoV-2.
    Wang S; Ye J; Kang Z; Peng H; Mackey V; Sun L
    Am J Transl Res; 2021; 13(3):871-881. PubMed ID: 33841627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
    Lai CC; Shih TP; Ko WC; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2020 Mar; 55(3):105924. PubMed ID: 32081636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
    Bchetnia M; Girard C; Duchaine C; Laprise C
    J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).
    Park SE
    Clin Exp Pediatr; 2020 Apr; 63(4):119-124. PubMed ID: 32252141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
    Lai CC; Liu YH; Wang CY; Wang YH; Hsueh SC; Yen MY; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):404-412. PubMed ID: 32173241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
    Abd El-Aziz TM; Stockand JD
    Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
    Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
    JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic sequence, origin, and diagnosis of SARS-CoV-2.
    Wang H; Li X; Li T; Zhang S; Wang L; Wu X; Liu J
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1629-1635. PubMed ID: 32333222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.
    Yan Y; Shin WI; Pang YX; Meng Y; Lai J; You C; Zhao H; Lester E; Wu T; Pang CH
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32235575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.
    Rabaan AA; Al-Ahmed SH; Sah R; Tiwari R; Yatoo MI; Patel SK; Pathak M; Malik YS; Dhama K; Singh KP; Bonilla-Aldana DK; Haque S; Martinez-Pulgarin DF; Rodriguez-Morales AJ; Leblebicioglu H
    Ann Clin Microbiol Antimicrob; 2020 Sep; 19(1):40. PubMed ID: 32878641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus.
    Jan H; Faisal S; Khan A; Khan S; Usman H; Liaqat R; Shah SA
    Discoveries (Craiova); 2020 Apr; 8(2):e108. PubMed ID: 32377559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
    Sharma A; Tiwari S; Deb MK; Marty JL
    Int J Antimicrob Agents; 2020 Aug; 56(2):106054. PubMed ID: 32534188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.